[{"Assets_0_Q2_USD":"59424000000.0","CIK":"818686","CommonStockSharesConverted_0_Q2_shares":"1198000000.0","Country":"Israel","EarningsPerShareBasic_1_Q2_USD":"-0.63","EarningsPerShareBasic_2_Q2_USD":"-0.73","EarningsPerShareDiluted_1_Q2_USD":"-0.63","EarningsPerShareDiluted_2_Q2_USD":"-0.73","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"11303387401.0","MinorityInterest_0_Q2_USD":"1128000000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"-115000000.0","NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":"-689000000.0","NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":"-794000000.0","NetIncomeLoss_1_Q2_USD":"-689000000.0","NetIncomeLoss_2_Q2_USD":"-794000000.0","OfficialName":"Teva Pharmaceutical Industries Limited American Depositary Shares","ProfitLoss_1_Q2_USD":"-671000000.0","ProfitLoss_2_Q2_USD":"-768000000.0","RevenuesConverted_1_Q2_USD":"4337000000.0","RevenuesConverted_2_Q2_USD":"8632000000.0","SP500":null,"Sector":"Health Care","StockholdersEquityConverted_0_Q2_USD":"15251000000.0","StockholdersEquity_0_Q2_USD":"14122000000.0","Ticker":"TEVA","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":"1092000000.0","WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":"1091000000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":"1092000000.0","WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":"1091000000.0","filed":"20190807","footnote":null,"form":"10-Q","fp":"Q2","fy":"2019.0","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","period":"20190630","qtrs":"0","uom":"USD"}]